PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 7 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 7 months ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 7 months ago Biophytis fait le point sur ses programmes d’accès précoce pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 7 months ago Biophytis renforce sa direction avec la nomination de son Chief Business Officer
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 7 months ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 7 months ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 7 months ago Biophytis obtient l’autorisation de la FDA pour démarrer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 8 months ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 8 months ago Biophytis participera à la 25ème Global Investment Conference de H.C. Wainwright à New York
PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 8 months ago Biophytis announces next regulatory steps in Europe and the United States for its COVA project
Published on 05/09/2026 at 01:30, 5 hours 43 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 7 hours 13 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 10 hours 35 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 12 hours 1 minute ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 12 hours 11 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 11 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 11 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 12 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 12 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 12 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
